You have 9 free searches left this month | for more free features.

City

Tokyo (2)

Hidaka (1)

Hiroshima (1)

Kumamoto (1)

Kyoto (1)

Nagoya (1)

Osaka (1)

Sagamihara (1)

Sendai (1)

Condition

Glioma (1)

WHO Grade II Glioma (1)

Overall Status

Active, not recruiting (2)

Phase

n/a (1)

phase 2 (1)

Sponsor

Daiichi Sankyo Co., Ltd. (2)

Collaborator

Daiichi Sankyo, Inc. (1)

Intervention

ds-1001b (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

ds-1001b

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glioma Trial in Tokyo (DS-1001b)

Active, not recruiting

Glioma

DS-1001b

Tokyo, Japan

National Cancer Center Hospital

Feb 2, 2022

WHO Grade II Glioma Trial in Japan (DS-1001b)

Active, not recruiting

WHO Grade II Glioma

DS-1001b

Nagoya, Aichi, Japan
+10 more

Feb 3, 2022